Given the pivotal role for Sox2 in stem cell self-renewal, BCSLC development and breast cancer outcomes [27, 60–63], AHR/Sox2-specific ChIP assays were performed to determine if the AHR directly interacts with the Sox2 promoter. This evidence concerns the gene AHR and breast carcinoma.